A Novel Solution For A Novel Virus: Leading Biotech CEO Dr. Vipin Garg Of Altimmune episode artwork

EPISODE · Jun 15, 2021 · 20 MIN

A Novel Solution For A Novel Virus: Leading Biotech CEO Dr. Vipin Garg Of Altimmune

from Growth Investor with GrowthCap‘s RJ Lumba · host RJ Lumba

In this episode, we chat with Dr. Vipin Garg, the President and CEO of Altimmune, a biotech company pioneering the development of intranasal vaccines and therapeutics, including ones that can prevent the transmission of and treat COVID. He has more than three decades of experience in the biotechnology and pharmaceutical industries with a successful track record building and leading notable private and publicly traded companies. Dr. Garg was named a Top 25 Biotech CEO of 2021 by The Healthcare Technology Report.  He received his PhD in Biochemistry in 1982 from the University of Adelaide, Australia, and his Master of Science degree from IARI Nuclear Research. We hope you enjoy the show.

Episode metadata supplied by the publisher feed · Published Jun 15, 2021

Embed this episode

NOW PLAYING

A Novel Solution For A Novel Virus: Leading Biotech CEO Dr. Vipin Garg Of Altimmune

0:00 20:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Growth Investor with GrowthCap‘s RJ Lumba?

This episode is 20 minutes long.

When was this Growth Investor with GrowthCap‘s RJ Lumba episode published?

This episode was published on June 15, 2021.

Can I download this Growth Investor with GrowthCap‘s RJ Lumba episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!